Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
28 mai 2021 08h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today...
Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight Report 2021-2026 Featuring Acopedia, Takeda Pharma, TC Biopharma and Adapate Therapeutics
20 mai 2021 05h58 HE
|
Research and Markets
Dublin, May 20, 2021 (GLOBE NEWSWIRE) -- The "Global Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. ...
Global CAR-T Therapy Pipeline Market Analysis Report 2021: Focus on CD19, CD22, Others - Long-term Forecast to 2025 & 2030
11 mai 2021 05h33 HE
|
Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Harpoon Therapeutics to Participate in Truist Securities Life Sciences Summit
28 avr. 2021 16h05 HE
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today...
Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021
10 avr. 2021 08h30 HE
|
Harpoon Therapeutics
SOUTH SAN FRANCISCO, Calif., April 10, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today...
Achilles Therapeutics Announces Pricing of Initial Public Offering
30 mars 2021 19h00 HE
|
Achilles Therapeutics PLC
LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today...
Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
24 mars 2021 07h00 HE
|
Vineti
Genentech, Takeda, Adaptimmune and other industry leaders join Vineti to form the core of this strategic collaboration. The group is focused on working industry-wide to promote new and updated...
Global T-Cell Therapies Market Report 2021: Type of Therapy, Target Indications, Target Antigens, Key Players and Key Regions 2020-2030
19 févr. 2021 04h33 HE
|
Research and Markets
Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "Global T-Cell Therapies Market - Distribution by Type of Therapy, Target Indications, Target Antigens, Key Players and Key Regions: Industry Trends and...
T-Cell Immunotherapy Market Report 2021 - Global Forecast to 2025: Opportunities of Commercialisation and Funding by Pharmaceutical Companies
15 févr. 2021 05h28 HE
|
Research and Markets
Dublin, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Research Report by Mechanism Of Action, by Type of Therapy, by Indication - Global Forecast to 2025 - Cumulative Impact of...
Global Apoptosis Assays Market Report 2020: Apoptosis Assay Kits Lead the Demand with 42.5% Share - Forecast to 2026
01 févr. 2021 04h08 HE
|
Research and Markets
Dublin, Feb. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Apoptosis Assays Market - Products, Detection Technologies, Applications and End-Use Markets" report has been added to ResearchAndMarkets.com's...